Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
World Neurosurgery 2020-Apr

Management of Aneurysmal Subarachnoid Hemorrhage - Variation in Clinical Practice and Unmet Need for Follow-up among Survivors - A Single Center Perspective.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
Claire Delpirou-Nouh
Danny Samkutty
Swathy Chandrashekhar
Joshua Santucci
Lance Ford
Chao Xu
Kimberly Hollabaugh
Bradley Bohnstedt
Bappaditya Ray

Raktažodžiai

Santrauka

Purpose of the present study is to investigate the existence and/or prevalence of clinical practice variation in management of aneurysmal subarachnoid hemorrhage (aSAH) and to determine need for long-term follow-up.Single-center study of aSAH patients over a 5-year period divided into two halves (2.5 years each) before and after addition of a dually trained cerebrovascular neurosurgeon. In-hospital clinical practice, clinical outcome (mortality, discharge destination) and long-term outcome (modified Rankin scale, mRS and telephone interview for cognitive status, TICS) were compared using descriptive summaries and non-parametric tests.Among 251 aSAH patients admitted, 115 (45.8%) were prior to the index event, while 136 (54.2%) were during the later period. The aneurysm securing procedure changed from coil embolization to clip ligation [12/115 (10.4%) vs. 84/136 (61.8%), p<0.0001] during the latter years. Interventional treatment for cerebral vasospasm has decreased [58/115 (50.4%) vs. 49/136 (36.0%), p=0.0002]. Patients surviving hospitalization had more clinic follow-up post-discharge during the latter period [42/85 (49.4%) vs. 76/105 (72.4%), p=0.0012] and ventriculoperitoneal shunt placement for delayed hydrocephalus [1/85 (1.2%) vs. 9/105 (8.6%), p=0.02]. A sub-cohort (n=46) of aSAH survivors had lower median TICS score during the earlier study period [31.5 (IQR 22, 36) vs. 33 (IQR 27, 38), p=0.038]. Similarly, pre-ictal smoking status and hyperlipidemia were associated with adverse TICS score in a multivariate model (p=0.007).Post-discharge clinic follow-up has improved facilitating recognition and treatment of delayed hydrocephalus. Existence of cognitive deficits among survivors call for establishment of multidisciplinary clinics for long-term aSAH management.

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge